Forbes March 1, 2023
“It takes 12 years and $2.6 billion to bring a drug to market,” said Michelle Longmire, MD, CEO at Medable. The company has raised over $500 million to improve the clinical trial process and achieved unicorn status in 2021.
Boosted by the adoption of digital technologies during the Covid-19 pandemic, many parts of the healthcare industry are being transformed, including how clinical trials are conducted. When clinical trials couldn’t be done in person, Medable proved to be an indispensable resource.
Even though in-person clinical trials are again possible, Medable continues to be indispensable in clinical trials because it speeds up the process of recruitment, reduces costs, and enables outreach to underrepresented populations.
Longmire is a physician-scientist who loves inventing, especially...
Today's Sponsors
Today's Sponsor